Cargando…
Quantitative Assessment of Tissue Biomarkers and Construction of a Model to Predict Outcome in Breast Cancer Using Multiple Imputation
Missing data pose one of the greatest challenges in the rigorous evaluation of biomarkers. The limited availability of specimens with complete clinical annotation and quality biomaterial often leads to underpowered studies. Tissue microarray studies, for example, may be further handicapped by the lo...
Autores principales: | Emerson, John W., Dolled-Filhart, Marisa, Harris, Lyndsay, Rimm, David L., Tuck, David P. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2664700/ https://www.ncbi.nlm.nih.gov/pubmed/19352457 |
Ejemplares similares
-
Computational and Bioinformatics Frameworks for Next-Generation Whole Exome and Genome Sequencing
por: Dolled-Filhart, Marisa P., et al.
Publicado: (2013) -
Optimal tumor sampling for immunostaining of biomarkers in breast carcinoma
por: Tolles, Juliana, et al.
Publicado: (2011) -
Quantitative Measurement of Cancer Tissue Biomarkers in the Lab and in the Clinic
por: Carvajal-Hausdorf, Daniel, et al.
Publicado: (2014) -
Development of a Companion Diagnostic PD-L1 Immunohistochemistry Assay for Pembrolizumab Therapy in Non–Small-cell Lung Cancer
por: Roach, Charlotte, et al.
Publicado: (2016) -
PD-L1 Expression and Survival among Patients with Advanced Non–Small Cell Lung Cancer Treated with Chemotherapy()
por: Sorensen, Steffen Filskov, et al.
Publicado: (2016)